U Chandavarkar, M Campan… - GYNECOL …, 2011 - discovery.ucl.ac.uk ... DNA methylation markers associated with serous ovarian cancer subtypes. ... 10.1016/j.ygyno. 2010.12.117. Full text not available from this repository. Type: Article. Title: DNA methylation markers associated with serous ovarian cancer subtypes. DOI: 10.1016/j.ygyno.2010.12.117. ... Cached - All 2 versions
ZHY Wu, RYK Lai, YWY Yip, WM Chan, DSC Lam… - Retina, 2011 - journals.lww.com Methods: Thirty-four patients with acute central serous chorioretinopathy were randomly assigned to receive photodynamic therapy with half-dose verteporfin (n = 24) or placebo (n = 10). Multifocal electroretinography was performed at baseline and at 12 months, and serial changes in ... Related articles - All 5 versions
A Shabaik, G Lin, M Peterson… - Diagnostic …, 2011 - Wiley Online Library The prognostic and predictive value of Her2/neu and the hormone receptors in patient with primary or metastatic breast cancer is essential for a favorable outcome of treatment. We have been experiencing increasing requests to test cytologic specimens for these markers in patients with ... Related articles - All 2 versions
[HTML] from nih.govAM Karst, K Levanon… - Proceedings of the …, 2011 - National Acad Sciences High-grade serous ovarian carcinoma (HGSOC) is a lethal disease for which improved screening and treatment strategies are urgently needed. Progress in these areas is impeded by our poor understanding of HGSOC pathogenesis. Most ovarian cancer research is based on the ... Cited by 3 - Related articles - All 5 versions
TA Longacre - Surgical Pathology Clinics, 2011 - Elsevier This review focuses on recent advances in the area of low-grade ovarian serous neoplasia with emphasis on key diagnostic criteria, differential diagnosis, and disease classification based on current understanding of low-grade serous carcinogenesis. Despite considerable ... All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
